pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Pulmonology · news · pharmadog
← back to Pulmonology
News · Pulmonology
512
stories
6d
Merck, Daiichi scrap FDA application for B7-H3 ADC in lung cancer
endpoints
6d
Regenerative medicine needs more than stem cells
biospace
6d
6 immunology targets to sustain a mammoth I&I market
biospace
6d
Merck, Daiichi pull lung cancer filing after FDA pushback deals another blow to $4B deal
fiercebiotech
9d
Opinion: The ‘died with’ vs. ‘died of’ measles discussion misses something very important
stat
10d
Grail multicancer detection test wins FDA advisers’ backing
biopharma dive
10d
China’s Henlius carves out $440M T-cell engager deal with Amberstone
fiercebiotech
10d
Opinion: Measles almost killed me. Now I’m a doctor — and I’m scared of what’s happening
stat
10d
Grail survives adcomm vote as it awaits FDA decision for cancer blood test
fiercebiotech
11d
9 companies hiring in Pennsylvania now
biospace
11d
ReCode CEO Suliman leaves cystic fibrosis mission in mentee’s hands
biospace
11d
Early Alert: Ventilator Issue from React Health
fda medwatch
12d
Compass vows to press on with FDA application despite new trial request
biospace
12d
Lilly presents early data supporting GLP-1/GIP candidate's potential in depression, alcohol use disorder
biospace
12d
GSK aiming to ‘balance West and East’ after Hansoh deal success showed China’s potential
fiercebiotech
12d
Otsuka heads to FDA as Ionis-partnered ALS drug hits primary phase 3 endpoint
fiercebiotech
12d
Opinion: The science on relieving cancer symptoms is clear. Why isn’t insurance paying?
stat
12d
Iambic maintains momentum from string of Big Pharma partnerships by aiming for IPO
fiercebiotech
13d
Telix buys ITM for $1.65B in ‘supercritical’ radiopharma M&A
biospace
13d
Behind the outcomes: How whole-patient support is reshaping oncology care
biopharma dive
13d
Analysts ‘extremely bullish’ as Telix beams into Novartis’ territory with $1.6B ITM acquisition
fiercebiotech
13d
Citing Replimune approval, experts say localized cancer meds could redefine care
biospace
13d
Ventilator Recall: CooperSurgical Removes INCA Infant Nasal CPAP Sets
fda medwatch
16d
Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter
fda recalls
16d
China plans to transform biotech sector into $522B powerhouse by 2030
biospace
16d
This week in charts: GSK’s China deals, the $300M IPO club and selling the news
biopharma dive
16d
STAT+: Roche expands its Boston footprint with new research center
stat
16d
Who supports policies for ‘health equity’? It depends on how you’re asking
stat
16d
FDA clears Aptitude’s latest Metrix molecular dx to test for COVID
fiercebiotech
16d
Nitric Oxide Delivery System Correction: NOxBOX Updates Use Instructions for NOxBOXi Nitric Oxide Delivery System
fda medwatch
← prev
page 2 of 18
next →
